Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-06-07

FDA Approved: FLUPHENAZINE HYDROCHORIDE — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved Rising Pharma Holdings' generic fluphenazine hydrochloride via Original Application (ANDA), a generic antipsychotic used to treat schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluphenazine hydrochloride (Fluphenazine hydrochloride)

Snippet

ORIG AP for FLUPHENAZINE HYDROCHORIDE (FLUPHENAZINE HYDROCHLORIDE)